Product images are for illustrative purposes only. Not actual patient data.
Medicare coverage is available for the FreeStyle Libre systems if their respective readers are used to review glucose data on some days every month. Medicare and other third party payor criteria apply.
Abbott provides this information as a courtesy; it is subject to change and interpretation. The customer is ultimately responsible for determining the appropriate codes, coverage, and payment policies for individual patients. Abbott does not guarantee third party coverage or payment for our products or reimburse customers for claims that are denied by third party payors.
The LibreView data management software is intended for use by both patients and healthcare professionals to assist people with diabetes and their healthcare professionals in the review, analysis and evaluation of historical glucose meter data to support effective diabetes management. The LibreView software is not intended to provide treatment decisions or to be used as a substitute for professional healthcare advice.
The FreeStyle Libre 3 system and FreeStyle Libre 2 system are indicated for patients ages 4 and older.
* Data from this study was collected with the outside US version of the FreeStyle Libre 14 day system. FreeStyle Libre 3 has the same features as FreeStyle Libre 14 day system with real-time glucose alarms. Therefore the study data is applicable to both products.
† Data from this study was collected with the outside US version of the FreeStyle Libre 14 day system. FreeStyle Libre 2 has the same features as FreeStyle Libre 14 day system with optional real-time glucose alarms. Therefore the study data is applicable to both products.
‡ Fingersticks are required if your glucose alarms and readings do not match symptoms or when you see Check Blood Glucose symbol during the first 12 hours.
§ The FreeStyle Libre 2 app and FreeStyle Libre 3 app are only compatible with certain mobile devices and operating systems. Please check our website for more information about device compatibility before using the app. Use of the FreeStyle Libre 2 app or the FreeStyle Libre 3 app may require registration with LibreView.
|| The FreeStyle Libre 3 app and the FreeStyle Libre 3 reader have similar but not identical features. Fingersticks are required for treatment decisions when you see the Check Blood Glucose symbol and when your glucose alarms and readings from the system do not match symptoms or expectations.
¶ The FreeStyle Libre 2 app and the FreeStyle Libre 2 reader have similar but not identical features. Fingersticks are required for treatment decisions when you see Check Blood Glucose symbol and when your glucose alarms and readings from the system do not match symptoms or expectations
# Notifications will only be received when alarms are turned on and the sensor is within 33 feet unobstructed of the reading device. You must enable the appropriate settings on your smartphone to receive alarms and alerts, see the FreeStyle Libre 3 User’s Manual for more information.
** Notifications will only be received when alarms are turned on and the sensor is within 20 feet unobstructed of the reading device. You must enable the appropriate settings on your smartphone to receive alarms and alerts, see the FreeStyle Libre 2 User’s Manual for more information.
†† The LibreLinkUp app is only compatible with certain mobile devices and operating systems. Please check http://www.librelinkup.com for more information about device compatibility before using the app. Use of the LibreLinkUp app requires registration with LibreView. LibreLinkUp is not intended to be used for dosing decisions. The user should follow instructions on the continuous glucose monitoring system. LibreLinkUp is not intended to replace self-monitoring practices as advised by a physician.
‡‡ Data based on the number of patients assigned to each manufacturer based on last filled prescription in US Retail and DME.
§§ Data based on the number of users worldwide for FreeStyle Libre family of personal CGMs compared to the number of users for other leading personal CGM brands and based on CGM sales dollars compared to other CGM brands.
References:
1. Unger J, et al. Postgrad Med. (2020): https://doi.org/10.1080/00325481.2020.1744393 2. FreeStyle Libre 3 User’s Manual. 3. Carlson AL, et al. BMJ Open Diabetes Res Care (2022): https://doi.org/10.1136/bmjdrc-2021-002590 4. Evans M, et al. Diabetes Ther (2022): https://doi.org/10.1007/s13300-022-01253-9 5. Wright, E. Diabetes Spectr (2021): https://doi.org/10.2337/ds20-0069 6. Kroger, J. Diabetes Ther (2020): https://doi.org/10.1007/s13300-019-00741-9 7. Tyndall, V. Diabetologia (2019): https://doi.org/10.1007/s00125-019-4894-1 8. Yaron, M. Diabetes Care (2019): https://doi.org/10.2337/dc18-0166 9. Campbell, F. Pediatr Diabetes (2018): https://doi.org/10.1111/pedi.12735 10. Bolinder, J. The Lancet (2016): https://doi.org/10.1016/s0140-6736(16)31535-5 11. Haak, T. Diabetes Ther (2017): https://doi.org/10.1007/s13300-016-0223-6 12. Data on file, Abbott Diabetes Care.
Stay connected